Lebenthal Holdings’s Celgene Corp CELG Stock Holding History

Lebenthal Holdings’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.92M	Sell	19,486 -1,185	-6%	-$123K	0.24%	139
2016 Q1	$2.07M	Buy	20,671 +6,185	+43%	+$637K	0.36%	95
2015 Q4	$1.74M	Sell	14,486 -3,039	-17%	-$352K	0.41%	99
2015 Q3	$1.9M	Sell	17,525 -5,832	-25%	-$724K	0.44%	92
2015 Q2	$2.85M	Buy	23,357 +8,519	+57%	+$974K	0.58%	43
2015 Q1	$1.71M	Buy	14,838 +6,838	+85%	+$817K	0.4%	105
2014 Q4	$895K	Buy	+8,000	New	+$844K	0.39%	74

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Lebenthal Holdings's CELG Position: Q2 2016 in Review

Lebenthal Holdings reduced its Celgene Corp (CELG) stake by 5.7% in Q2 2016, selling an estimated $123K and leaving 19,486 shares worth $1.92M. The position accounts for 0.24% of the portfolio, ranked #139.

Lebenthal Holdings first reported a position in CELG in Q4 2014 and has held it in 7 quarters since. The position peaked at $2.85M in Q2 2015. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

Lebenthal Holdings held 19,486 shares of Celgene Corp worth $1.92M as of Q2 2016.
Lebenthal Holdings sold 1,185 Celgene Corp shares in Q2 2016, an estimated $123K.
Celgene Corp made up 0.24% of Lebenthal Holdings's portfolio in Q2 2016, its #139 holding.
Lebenthal Holdings first reported a position in Celgene Corp in Q4 2014 and has held it in 7 quarters since.
Lebenthal Holdings's Celgene Corp position peaked at $2.85M in Q2 2015.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.